Home

James R. Kasinger, General Counsel and Secretary: Crispr Therapeutics CRSP Sell · Filed 25/03/24

Trade details

Type
Insider sale
Amount
$131,317.55
Shares · price
3,185 sh · $41.23 a share
Held after
81,729 sh
Trade date
25/03/21
Filed
25/03/24
Days to filing
3 days

Sold 3.8% of holdings

Share of holding sold
3.8%

Crispr Therapeutics trades, last 26 weeks

What else happened in Crispr Therapeutics around then

Filed or reported within 30 days of the trade day · 25/02/19~25/04/20

James R. Kasinger's recent trades

  • James R. Kasinger

    Sell10b5-1 planCrispr Therapeutics

    $626.5K

    Filed 09/24

  • James R. Kasinger

    Planned sale10b5-1 planCrispr Therapeutics

    $626.5K

    Filed 09/22

  • James R. Kasinger

    SellCrispr Therapeutics

    $148.9K

    Filed 03/24

  • James R. Kasinger

    SellCrispr Therapeutics

    $166.5K

    Filed 03/17

  • James R. Kasinger

    SellCrispr Therapeutics

    $147.8K

    Filed 03/12